XML 34 R24.htm IDEA: XBRL DOCUMENT
v3.24.4

Stockholders’ Equity (Tables) | 9 Months Ended
--- | ---
Nov. 30, 2024
Equity [Abstract] |
Schedule of Stock Option Activity | Option activity for the nine months ended November 30, 2024 and the year ended February 29, 2024 was as follows: Schedule of Stock Option Activity
|  | Options |  |  | Weighted Average Exercise Price ($) |  |  | Weighted Average Remaining Contractual Life (Yrs.) |  |  | Aggregate Intrinsic Value ($) |
Options outstanding at February 28, 2023 |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Options assumed pursuant to reverse acquisition |  |  | 86,642 |  |  |  | 61.43 |  |  |  | 2.68 |  |  |  | - |
Granted |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Exercised |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Forfeited or cancelled |  |  | (1,342 | ) |  |  | 120.87 |  |  |  | - |  |  |  | - |
Options outstanding at February 29, 2024 |  |  | 85,300 |  |  |  | 60.50 |  |  |  | 2.52 |  |  |  | - |
Granted |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Exercised |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Forfeited or cancelled |  |  | (6,433 | ) |  |  | 87.13 |  |  |  | - |  |  |  | - |
Options outstanding November 30, 2024 |  |  | 78,867 |  |  |  | 58.18 |  |  |  | 1.78 |  |  |  | - |
Options expected to vest in the future as of November 30, 2024 |  |  | 721 |  |  |  | 41.43 |  |  |  | 2.71 |  |  |  | - |
Options exercisable at November 30, 2024 |  |  | 78,146 |  |  |  | 58.33 |  |  |  | 1.78 |  |  |  | - |
Options vested, exercisable, and options expected to vest at November 30, 2024 |  |  | 78,867 |  |  |  | 58.18 |  |  |  | 1.78 |  |  |  | - |
Schedule of Stock Appreciation Rights Activity | SARs activity for the nine months ended November 30, 2024 and the year ended February 29, 2024 was as follows: Schedule of Stock Appreciation Rights Activity
|  | SARs |  |  | Weighted Average Exercise Price ($) |  |  | Weighted Average Remaining Contractual Life (Yrs.) |  |  | Aggregate Intrinsic Value ($) |
SARs outstanding at February 28, 2023 |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
SARs assumed pursuant to reverse acquisition |  |  | 40,390 |  |  |  | 44.77 |  |  |  | 2.99 |  |  |  | - |
Exercised |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Forfeited or cancelled |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
SARs outstanding at February 29, 2024 |  |  | 40,390 |  |  |  | 44.77 |  |  |  | 2.99 |  |  |  | - |
Granted |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Exercised |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Forfeited or cancelled |  |  | (167 | ) |  |  | 37.40 |  |  |  | - |  |  |  | - |
SARs outstanding November 30, 2024 |  |  | 40,223 |  |  |  | 44.80 |  |  |  | 2.23 |  |  |  | - |
SARs expected to vest in the future as of November 30, 2024 |  |  | 5,429 |  |  |  | 28.55 |  |  |  | 2.59 |  |  |  | - |
SARs exercisable at November 30, 2024 |  |  | 34,794 |  |  |  | 47.33 |  |  |  | 2.18 |  |  |  | - |
SARs vested, exercisable, and SARs expected to vest at November 30, 2024 |  |  | 40,223 |  |  |  | 44.80 |  |  |  | 2.23 |  |  |  | - |
Schedule of Warrant Activity | Warrant activity for the nine months ended November 30, 2024 and the year ended February 29, 2024 was as follows: Schedule of Warrant Activity
|  | Warrants |  |  | Weighted Average Exercise Price ($) |  |  | Weighted Average Remaining Contractual Life (Yrs.) |
Warrants outstanding at February 28, 2023 |  |  | - |  |  |  | - |  |  |  | - |
Warrants assumed pursuant to reverse acquisition |  |  | 217,593 |  |  |  | 21,01 |  |  |  | 1.86 |
Granted |  |  | 268,572 |  |  |  | 3.02 |  |  |  | 2.17 |
Exercised |  |  | - |  |  |  | - |  |  |  | - |
Forfeited or cancelled |  |  | - |  |  |  | - |  |  |  | - |
Warrants outstanding at February 29, 2024 |  |  | 486,165 |  |  |  | 9.94 |  |  |  | 1.96 |
Granted |  |  | 196,774 |  |  |  | 3.18 |  |  |  | 1.99 |
Exercised |  |  | - |  |  |  | - |  |  |  | - |
Forfeited or cancelled |  |  | (3,202 | ) |  |  | 108.37 |  |  |  | - |
Warrants outstanding at November 30, 2024 |  |  | 679,737 |  |  |  | 6.52 |  |  |  | 1.98 |

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for stock options and stock appreciation rights that were outstanding at the beginning and end of the year, exercisable at the end of the year, and the number of stock options and stock appreciation rights that were granted, exercised or converted, forfeited, and expired during the year. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-1 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration